Inalways Cash Flow Conversion Efficiency

Latest as of June 2026: 0.012x

Inalways cash flow conversion efficiency. Based on the latest financial reports, Inalways (5398) has a cash flow conversion efficiency ratio of 0.012x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$6.08 Million ≈ $191.43K USD) by net assets (NT$518.67 Million ≈ $16.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Inalways (2015–2025)

Cash flow conversion efficiency of Inalways from 2015 to 2025. This chart illustrates how Inalways's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Inalways for real-time trading data and today's change.

Inalways Cash Flow Conversion Ratio Explained

Inalways cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Inalways Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inalways ranked by their cash flow conversion efficiency. Also see market value of Inalways for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Latch Inc
NASDAQ:LTCH
-0.071x
Fidelity European Values
LSE:FEV
0.003x
Oxford Nanopore Technologies Ltd
LSE:ONT
-0.093x
THE INX DIGITAL CO.INC.
F:FN4
N/A
Sc Engineering
KO:023960
-0.308x
Prestar Resources Bhd
KLSE:9873
-0.011x
BeLive Holdings Ordinary Share
NASDAQ:BLIV
N/A
Franklin Wireless Corp
NASDAQ:FKWL
0.000x

Annual Cash Flow Conversion Efficiency for Inalways (2015–2025)

The table below shows the annual cash flow conversion efficiency of Inalways from 2015 to 2025. Review Inalways free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$530.62 Million
≈ $16.72 Million
NT$9.14 Million
≈ $288.02K
0.017x +139.91%
2024-12-31 NT$546.17 Million
≈ $17.21 Million
NT$-23.58 Million
≈ $-742.90K
-0.043x -171.14%
2023-12-31 NT$504.59 Million
≈ $15.90 Million
NT$30.62 Million
≈ $964.76K
0.061x +246.17%
2022-12-31 NT$539.52 Million
≈ $17.00 Million
NT$-22.40 Million
≈ $-705.72K
-0.042x -122.66%
2021-12-31 NT$562.96 Million
≈ $17.74 Million
NT$103.15 Million
≈ $3.25 Million
0.183x +1710.75%
2020-12-31 NT$566.84 Million
≈ $17.86 Million
NT$-6.45 Million
≈ $-203.15K
-0.011x -147.41%
2019-12-31 NT$560.74 Million
≈ $17.67 Million
NT$13.45 Million
≈ $423.84K
0.024x +2286.81%
2018-12-31 NT$530.49 Million
≈ $16.71 Million
NT$-582.00K
≈ $-18.34K
-0.001x -100.63%
2017-12-31 NT$627.01 Million
≈ $19.75 Million
NT$108.36 Million
≈ $3.41 Million
0.173x +486.84%
2016-12-31 NT$605.72 Million
≈ $19.08 Million
NT$-27.06 Million
≈ $-852.57K
-0.045x -41.71%
2015-12-31 NT$292.23 Million
≈ $9.21 Million
NT$-9.21 Million
≈ $-290.26K
-0.032x --

About Inalways

TWO:5398 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$25.01 Million
NT$793.92 Million TWD
Market Cap Rank
#24224 Global
#1515 in Taiwan
Share Price
NT$16.05
Change (1 day)
+3.22%
52-Week Range
NT$13.65 - NT$30.65
All Time High
NT$47.05
About

Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.